Neuromyelitis Optica (NMO)
What is Neuromyelitis Optica (NMO)?
Neuromyelitis Optica, also called NMO or Devic's disease, is a rare autoimmune condition. It attacks the protective coating around nerves in your eyes and spine. This coating is called myelin, and it helps nerve signals travel quickly through your body.
When your immune system mistakenly attacks this myelin, it causes inflammation and damage. This damage mainly affects your optic nerves, which connect your eyes to your brain, and your spinal cord. The result can be vision loss, weakness, numbness, and problems with bladder or bowel control.
NMO is different from multiple sclerosis, though the two conditions were once thought to be related. About 70 to 90 percent of people with NMO have antibodies against a protein called aquaporin-4. These antibodies are a hallmark of the disease. NMO is rare, affecting roughly 1 to 5 people per 100,000. It can happen at any age but most often appears between ages 30 and 50.
Symptoms
- Sudden vision loss or blurred vision in one or both eyes
- Eye pain that gets worse with movement
- Weakness or paralysis in arms or legs
- Numbness or tingling in limbs
- Loss of bladder or bowel control
- Uncontrollable vomiting or hiccups that last for days
- Severe muscle spasms or stiffness
- Fatigue and difficulty moving
Some people experience attacks that come and go over months or years. Others may have a single severe episode. Early symptoms can be mild and easy to overlook. Getting tested during an active attack helps confirm the diagnosis.
Concerned about Neuromyelitis Optica (NMO)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
NMO happens when your immune system creates antibodies that attack your own nervous system. Most commonly, these are antibodies against aquaporin-4, a protein found on cells that support nerve function. When these antibodies attack, they cause inflammation and destroy the myelin coating around nerves. Scientists are still learning why some people develop these antibodies, but genetics and environmental triggers may both play a role.
Women are 3 to 9 times more likely to develop NMO than men. The condition is more common in people of African, Asian, and Native American descent. Some people develop NMO after an infection or alongside other autoimmune conditions like lupus or Sjogren's syndrome. Having a family history of autoimmune disease may also increase your risk.
How it's diagnosed
Doctors diagnose NMO using a combination of clinical symptoms, blood tests, spinal fluid tests, and imaging. An MRI of your brain and spine can show areas of inflammation and damage. Blood tests check for aquaporin-4 antibodies, which are present in most people with NMO. Some people without aquaporin-4 antibodies may have antibodies against MOG, a different myelin protein.
Spinal fluid testing through a lumbar puncture may show elevated levels of Myelin Basic Protein during active disease. This protein appears when myelin breaks down. Specialized neurological testing is typically needed beyond routine blood work. Talk to our doctor about testing options and referrals to neurology specialists who can guide your diagnosis and treatment.
Treatment options
- Immediate high-dose corticosteroids to reduce inflammation during attacks
- Plasma exchange to remove harmful antibodies from your blood
- Immunosuppressive medications to prevent future attacks
- Monoclonal antibody treatments that target specific immune cells
- Physical therapy to maintain strength and mobility
- Occupational therapy to adapt daily activities
- Pain management for nerve pain and muscle spasms
- Bladder and bowel management strategies
Early treatment during attacks can prevent permanent nerve damage. Long-term preventive medications reduce the frequency and severity of relapses. Work closely with a neurologist who specializes in autoimmune neurological conditions. Lifestyle factors like stress management, adequate sleep, and avoiding infections can also help reduce attack risk.
Frequently asked questions
NMO and MS are both autoimmune conditions that damage myelin, but they target different areas. NMO specifically attacks the optic nerves and spinal cord, while MS can affect many areas of the brain and spinal cord. NMO is caused by antibodies against aquaporin-4 or MOG, while MS has a different underlying mechanism. Treatment approaches also differ between the two conditions.
NMO can be serious, but it is rarely fatal with proper treatment. Severe attacks affecting the brainstem or respiratory muscles can be life-threatening if not treated quickly. Early diagnosis and preventive treatment greatly improve outcomes. Many people with NMO manage their condition successfully with medication and maintain quality of life.
NMO symptoms typically develop over hours to days during an attack. Vision loss or weakness can worsen rapidly, reaching peak severity within one week. Some people have a single severe attack, while others experience multiple attacks months or years apart. Quick medical attention during an attack is critical to prevent permanent damage.
Routine blood panels do not detect NMO. Diagnosis requires specialized blood tests for aquaporin-4 or MOG antibodies. Spinal fluid testing may show elevated Myelin Basic Protein during active disease. MRI imaging is also essential for diagnosis. Work with a neurologist to order the appropriate specialized tests.
Vision loss from NMO can be permanent if attacks are not treated quickly. Immediate treatment with high-dose steroids or plasma exchange during an attack can help preserve vision. Preventive medications reduce the risk of future attacks. Some people recover partial or full vision after treatment, but outcomes vary depending on the severity of nerve damage.
NMO attacks can happen without an obvious trigger, but infections are a common cause. Stress, surgery, or vaccination may also precede attacks in some people. Staying current with preventive medications is the best way to reduce attack risk. Talk to your doctor about strategies to avoid infections and manage stress.
There is no cure for NMO, but effective treatments can prevent attacks and manage symptoms. Immunosuppressive medications and monoclonal antibodies can reduce or eliminate relapses. Many people achieve long periods without attacks when they stay on preventive therapy. Research into new treatments continues, offering hope for better options in the future.
While lifestyle changes cannot cure NMO, they may support overall health and reduce attack risk. Eating an anti-inflammatory diet rich in vegetables, fruits, and omega-3 fats may help. Managing stress through meditation or yoga can support immune health. Getting adequate sleep and avoiding infections are also important for reducing relapse risk.
Testing frequency depends on your disease activity and treatment plan. Your neurologist may order MRI scans every 6 to 12 months to monitor for new lesions. Blood work to check medication levels and side effects may be needed every few months. During an active attack, additional tests help guide immediate treatment decisions.
Many people with NMO can have children, but it requires careful planning with your neurologist. Some immunosuppressive medications are not safe during pregnancy and may need to be adjusted. NMO attacks can occur during pregnancy or shortly after delivery, so close monitoring is essential. Work with both your neurologist and obstetrician to create a safe pregnancy plan.